Canadians are advised not to buy or use products labelled in this way
Key Benefits Simultaneous GLP-1, GIP, and glucagon receptor agonism a triagonist profile unavailable in single or dual agonist compounds 30MG quantity eliminates mid-study reordering and the batch variability it introduces High-purity laboratory-grade formulation ensures clean receptor binding data and reproducible outcomes Full batch documentation covering identity, purity, and stability ready for institutional sourcing requirements and methods citations Stability-engineered packaging protects compound integrity from dispatch through to laboratory storage Features Compound type: Synthetic research peptide triagonist (GLP-1R / GIPR / GcgR) Quantity: 30MG per unit Grade: Laboratory research-grade Form: Lyophilised powder Quality control: Batch-tested identity, purity, and stability Packaging: Stability-preserving, light and moisture protected Intended use: Controlled in vitro and laboratory experimental use only Why Choose Retatrutide 30MG The distinction between Retatrutide 30MG and other compounds in its class comes down to receptor breadth
The most common side effect is mild discomfort at the injection site
Prepare Your Medication: Ensure your medication is at the recommended temperature
Documentation for the code 96372 CPT must show the order, the drug administered, dose/route/site, administration time, and the provider or staff who performed the injection
The Administration or reintroduction of any quantity of autologous, allogenic (homologous) or heterologous blood, or red blood cell products of any origin into the circulatory system
